Advisors Preferred’s Privia Health PRVA Stock Holding History

Advisors Preferred’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-82,458	Closed	-$1.7M	–	296
2026 Q1	$1.7M	Buy	+82,458	New	+$1.86M	0.25%	83
2024 Q1	–	Sell	-90,149	Closed	-$2.14M	–	264
2023 Q4	$2.14M	Buy	+90,149	New	+$2.02M	0.35%	66

Other funds holding PRVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Advisors Preferred's PRVA Position: Q2 2026 in Review

Advisors Preferred sold out of Privia Health (PRVA) in Q2 2026, closing a stake of 82,458 shares — an estimated $1.7M sold.

Advisors Preferred first reported a position in PRVA in Q4 2023 and held it in 2 quarters. The position peaked at $2.14M in Q4 2023. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

Advisors Preferred reported no remaining Privia Health position as of Q2 2026 after selling out during the quarter.
Advisors Preferred sold 82,458 Privia Health shares in Q2 2026, an estimated $1.7M.
Advisors Preferred first reported a position in Privia Health in Q4 2023 and held it in 2 quarters.
Advisors Preferred's Privia Health position peaked at $2.14M in Q4 2023.
301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Advisors Preferred's 13F filing for Q2 2026, filed 11 Aug 2026.